Apr 20, 2023 / 02:00AM GMT
David N. Cade - Telix Pharmaceuticals Limited - CEO of Asia Pacific
Good morning, everybody, and welcome to all of the audience. We are coming to you from Singapore. I'd like to extend a very warm welcome on behalf of Telix Leadership and the China Grand Pharma Leadership to this morning's investor webinar on the opportunity for radiopharmaceuticals in China.
Just a couple of messages I've been asked to pass on before we start. First of all, questions, we will hold till the end. And those who would like to ask a question can file a DM to the moderator, which is available down the bottom of the screen. And secondly, those who are listening in, who are native Chinese speakers or Mandarin speakers, there is a separate channel, which is accessible at the bottom of the Zoom screen as well.
Please read our -- next slide, please read our respective company disclaimers. Next slide, I think today, we have a very interesting agenda for the event. I'll introduce the co-speakers in a moment. We're going to start by just reviewing the Telix-Grand Pharma partnership, which is now 2.5 years mature. We
Telix Pharmaceuticals Ltd Grand Pharma Investor Webinar Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers